Solventum (SOLV) Competitors $74.92 +1.33 (+1.80%) As of 01/24/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SOLV vs. GEHC, PHG, ZBH, SNN, PEN, GKOS, BLCO, INSP, NARI, and PRCTShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry. Solventum vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew Penumbra Glaukos Bausch + Lomb Inspire Medical Systems Inari Medical PROCEPT BioRobotics Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation, community ranking and media sentiment. Does the media prefer SOLV or GEHC? In the previous week, GE HealthCare Technologies had 8 more articles in the media than Solventum. MarketBeat recorded 13 mentions for GE HealthCare Technologies and 5 mentions for Solventum. Solventum's average media sentiment score of 1.27 beat GE HealthCare Technologies' score of 1.12 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals and insiders believe in SOLV or GEHC? 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, SOLV or GEHC? GE HealthCare Technologies has higher revenue and earnings than Solventum. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.26B1.57N/AN/AN/AGE HealthCare Technologies$19.55B2.07$1.57B$3.6424.36 Do analysts prefer SOLV or GEHC? Solventum presently has a consensus price target of $68.29, suggesting a potential downside of 8.86%. GE HealthCare Technologies has a consensus price target of $96.00, suggesting a potential upside of 8.27%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67 Does the MarketBeat Community prefer SOLV or GEHC? GE HealthCare Technologies received 21 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 57.89% of users gave GE HealthCare Technologies an outperform vote while only 5.56% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.56%Underperform Votes1794.44% GE HealthCare TechnologiesOutperform Votes2257.89% Underperform Votes1642.11% Is SOLV or GEHC more profitable? GE HealthCare Technologies has a net margin of 8.56% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.19% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A GE HealthCare Technologies 8.56%25.19%5.93% SummaryGE HealthCare Technologies beats Solventum on 14 of the 15 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$12.95B$4.86B$5.43B$19.99BDividend YieldN/A52.56%5.37%3.62%P/E RatioN/A27.0188.9341.69Price / Sales1.5759.811,235.7317.61Price / CashN/A52.0644.3720.35Price / BookN/A8.175.085.78Net IncomeN/A$13.87M$117.95M$1.01B7 Day Performance1.81%3.97%3.12%1.58%1 Month Performance11.93%9.38%2.65%4.23%1 Year PerformanceN/A58.62%30.21%18.07% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum0.5209 of 5 stars$74.93+1.8%$68.29-8.9%N/A$12.95B$8.26B0.0022,000Positive NewsGEHCGE HealthCare Technologies2.8872 of 5 stars$84.74-0.3%$96.00+13.3%+21.7%$38.72B$19.55B23.2851,000Positive NewsPHGKoninklijke Philips2.6777 of 5 stars$25.82+0.3%N/A+17.1%$24.26B$19.66B-61.4669,656ZBHZimmer Biomet4.6342 of 5 stars$109.65+0.7%$123.33+12.5%-9.1%$21.83B$7.60B20.8518,000Analyst ForecastAnalyst RevisionNews CoverageSNNSmith & Nephew2.0682 of 5 stars$25.33+1.1%N/A-10.1%$11.07B$5.55B0.0018,452High Trading VolumePENPenumbra3.9228 of 5 stars$264.08+0.7%$258.00-2.3%+9.5%$10.14B$1.16B307.074,200Analyst ForecastGKOSGlaukos3.7957 of 5 stars$156.60+0.1%$147.75-5.6%+76.9%$8.63B$314.71M-51.85780News CoverageBLCOBausch + Lomb2.7969 of 5 stars$17.36-0.4%$20.42+17.6%+19.0%$6.12B$4.15B-16.5413,300High Trading VolumeINSPInspire Medical Systems4.6422 of 5 stars$177.97+2.4%$232.55+30.7%-11.4%$5.33B$624.80M166.331,011Analyst ForecastNews CoveragePositive NewsNARIInari Medical1.6206 of 5 stars$79.55+0.2%$68.00-14.5%+41.7%$4.66B$493.63M-58.931,300PRCTPROCEPT BioRobotics2.931 of 5 stars$76.02-3.6%$97.86+28.7%+59.4%$3.97B$136.19M-38.98430High Trading Volume Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives NARI Alternatives PRCT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:SOLV) was last updated on 1/26/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredNEW A.I. giant trading up to 84% less than MSFT – set to soar in 2025?I’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOLV Stock Alerts